Ralston brings more than 25 years of experience providing strategic Market Access and HEOR solutions.

Callio Therapeutics, a biotechnology company, has launched with the closing of a $187.0 million Series A financing round.

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

AbbVie and Gubra have partnered to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.

Veranova has moved its corporate headquarters to its Devens, Massachusetts site, one of its principal sites for manufacturing and development.

The U.S. Food and Drug Administration (FDA) has approved Fapon Biopharma’s Investigational New Drug (IND) application for ...

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery, has entered a collaboration and license ...

Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions.

Chief Science Officer, Peter Surman, shares insight on why pharmaceutical companies should consider softgels for their next ...

This paper provides experienced insights for biopharmaceutical professionals who are interested in optimizing their ...

Renaissance will optimize the formulation of intranasal Foralumab and assist with scaling up production for clinical trials.

Kineticos Life Sciences has launched Kinvard Bio Inc., a new anti-infectives biotech company based on research that has been ...